BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16259184)

  • 1. Do your part to stave off STREP.
    Schweon SJ
    RN; 2005 Oct; 68(10):34-8; quiz 39. PubMed ID: 16259184
    [No Abstract]   [Full Text] [Related]  

  • 2. Pneumococcal resistance in the postvaccine era.
    Temime L; Guillemot D; Boëlle PY
    Pediatr Infect Dis J; 2006 Apr; 25(4):382-3. PubMed ID: 16568001
    [No Abstract]   [Full Text] [Related]  

  • 3. Promises and challenges of pneumococcal conjugate vaccines for the developing world.
    Grijalva CG; Edwards KM
    Clin Infect Dis; 2006 Sep; 43(6):680-2. PubMed ID: 16912938
    [No Abstract]   [Full Text] [Related]  

  • 4. Childhood vaccination update. A new weapon against pneumococcal bacteria.
    Waldrop TB
    Adv Nurse Pract; 2001 Feb; 9(2):34-6, 39. PubMed ID: 12416052
    [No Abstract]   [Full Text] [Related]  

  • 5. Vaccination with the pneumococcal 7-valent conjugate: a successful experiment but the species is adapting.
    Beall B
    Expert Rev Vaccines; 2007 Jun; 6(3):297-300. PubMed ID: 17542743
    [No Abstract]   [Full Text] [Related]  

  • 6. Pneumonia vaccine protocol could save money and lives.
    Levenson D
    Rep Med Guidel Outcomes Res; 2002 Mar; 13(5):5-7. PubMed ID: 12440407
    [No Abstract]   [Full Text] [Related]  

  • 7. Changing epidemiology of antimicrobial-resistant Streptococcus pneumoniae in the United States, 2004-2005.
    Richter SS; Heilmann KP; Dohrn CL; Riahi F; Beekmann SE; Doern GV
    Clin Infect Dis; 2009 Feb; 48(3):e23-33. PubMed ID: 19115971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National paediatric immunization program of high risk groups: no effect on the incidence of invasive pneumococcal diseases.
    Rendi-Wagner P; Paulke-Korinek M; Kundi M; Burgmann H; Georgopoulos A; Vécsei A; Kollaritsch H
    Vaccine; 2009 Jun; 27(30):3963-8. PubMed ID: 19393711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pneumococcal disease and emergence of serotypes in the vaccine era. Transient trends and serotype replacement?].
    Moraga-Llop FA
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):1-4. PubMed ID: 19217995
    [No Abstract]   [Full Text] [Related]  

  • 10. Changing epidemiology of invasive pneumococcal disease: a complicated story.
    Black S
    Clin Infect Dis; 2008 Aug; 47(4):485-6. PubMed ID: 18627248
    [No Abstract]   [Full Text] [Related]  

  • 11. Serotype replacement in invasive pneumococcal disease: where do we go from here?
    Hanage WP
    J Infect Dis; 2007 Nov; 196(9):1282-4. PubMed ID: 17922390
    [No Abstract]   [Full Text] [Related]  

  • 12. Postvaccine genetic structure of Streptococcus pneumoniae serotype 19A from children in the United States.
    Pai R; Moore MR; Pilishvili T; Gertz RE; Whitney CG; Beall B;
    J Infect Dis; 2005 Dec; 192(11):1988-95. PubMed ID: 16267772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pneumococcal infections and risk factors: in whom should we prevent?].
    Perronne C
    Rev Pneumol Clin; 2001 Feb; 57(1 Pt 2):67-9. PubMed ID: 11428239
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased antimicrobial resistance among nonvaccine serotypes of Streptococcus pneumoniae in the pediatric population after the introduction of 7-valent pneumococcal vaccine in the United States.
    Farrell DJ; Klugman KP; Pichichero M
    Pediatr Infect Dis J; 2007 Feb; 26(2):123-8. PubMed ID: 17259873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Information from your family doctor. Pneumococcal conjugate vaccine: what a parent needs to know.
    Am Fam Physician; 2001 May; 63(10):2003-4. PubMed ID: 11388716
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of conjugate vaccine on transmission of antimicrobial-resistant Streptococcus pneumoniae among Alaskan children.
    Park SY; Moore MR; Bruden DL; Hyde TB; Reasonover AL; Harker-Jones M; Rudolph KM; Hurlburt DA; Parks DJ; Parkinson AJ; Schuchat A; Hennessy TW
    Pediatr Infect Dis J; 2008 Apr; 27(4):335-40. PubMed ID: 18316986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004.
    Hicks LA; Harrison LH; Flannery B; Hadler JL; Schaffner W; Craig AS; Jackson D; Thomas A; Beall B; Lynfield R; Reingold A; Farley MM; Whitney CG
    J Infect Dis; 2007 Nov; 196(9):1346-54. PubMed ID: 17922399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expected benefits of pneumococcal vaccination in Canadian infants and children < 5 years old.
    Can Commun Dis Rep; 2006 Mar; 32(5):45-54. PubMed ID: 16649291
    [No Abstract]   [Full Text] [Related]  

  • 19. [Invasive pneumococcal diseases in children and surveillance systems in Italy].
    Bagnato B; Marino MG; Franco E
    Ig Sanita Pubbl; 2008; 64(6):811-22. PubMed ID: 19219089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The shifting dynamics of pneumococcal invasive disease after the introduction of the pneumococcal 7-valent conjugated vaccine: toward the new pneumococcal conjugated vaccines.
    Greenberg D
    Clin Infect Dis; 2009 Jul; 49(2):213-5. PubMed ID: 19508164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.